Imaavy (nipocalimab-aahu) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating warm autoimmune hemolytic anemia (wAIHA) in adults and children ages 12 years and older.

Enjaymo (sutimlimab-jome) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating hemolysis in adults with cold agglutinin disease (CAD), a type of autoimmune hemolytic anemia (AIHA).